Clinical Policy Title: Outpatient diabetes self-management training (DSMT)

Similar documents
Clinical Policy Title: Cardiac rehabilitation

LOUISIANA MEDICAID PROGRAM ISSUED: 02/01/12 REPLACED: 02/01/94 CHAPTER 5: PROFESSIONAL SERVICES SECTION 5.1: COVERED SERVICES PAGE(S) 6

Cigna Medical Coverage Policy

Clinical Policy Title: Strep testing

8/12/2016. Outline. New CPT Code for Pre-Diabetes Education. Medicare Proposed Coverage for DPP. Medicare Proposed Coverage for DPP cont.

Clinical Policy Title: Ketamine for treatment-resistant depression

Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering)

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genicular nerve block

Clinical Policy Title: Zoster (shingles) vaccine

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System

Clinical Policy Title: Vacuum assisted closure in surgical wounds

Continuous Glucose Monitoring System

Corporate Medical Policy

Corporate Medical Policy

Clinical Policy Title: Abdominal aortic aneurysm screening

Insulin Pumps - External

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Artificial pancreas device system

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Continuous interstitial glucose monitoring (CGM)

Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified

If DSME* were a pill, would you prescribe it?

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness

Clinical Policy Title: Continuous interstitial glucose monitoring (CGM)

Diabetes Self-Management Education and Support Joint Position Statement

Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L34834 Status: A-Approved

Clinical Policy Title: Breast cancer index genetic testing

Medical Policy An independent licensee of the Blue Cross Blue Shield Association.

REVIEW AND FREQUENTLY ASKED QUESTIONS (FAQ) 8/5/2015. Outline. Navigating the DSMT Reimbursement Maze in Todays Changing Environment

Clinical Policy Title: Applied behavior analysis (ABA)

Diabetes Self-Management Education and Support (DSMES) Accreditation/Recognition 101

Gerald Bernstein, MD, Director, Diabetes Management Program. Marina Krymskaya, RN, MSN, ANP, CDE FDI Assistant Director

8/13/2016. A Joint DSME/S Position Statement One Year Later. DSME/S Position Statement: Collaboration. Definitions. ADA Standards of Medical Care

Clinical Policy Title: Computerized gait analysis

Clinical Policy Title: Ear tubes (tympanostomy)

Clinical Policy Title: Room humidifiers

Clinical Policy Title: Computerized gait analysis

Medicare s Current Diabetes Self-Management Training (DSMT) Coverage and Proposed Diabetes Prevention Program (DPP) Rule

13 B: Colorado Diabetes Burden Map. 15 References 15

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE

Continuous Glucose Monitoring (CGM)

What s App? Challenges and Opportunities in Diabetes Mobile Technologies

Continuous Glucose Monitoring (CGM)

Diabetes Education Columbus Community Hospital Stacy Biesel RN, CDE

Clinical Policy Title: Platelet rich plasma

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)

An Overview of Medicare Covered Diabetes Supplies and Services

Clinical Policy: Mifepristone (Korlym) Reference Number: CP.PHAR.101

Clinical Policy Title: Platelet rich plasma

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

External Insulin Pumps Corporate Medical Policy

Physical Activity/Exercise Prescription with Diabetes

Chronic Intermittent Intravenous Insulin Therapy

The Algorithm for DMSES Referrals: A toolkit made for Diabetes Educators to share critical referral times locally and nationally.

QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?

IABETES. Center for Diabetes Education* at Monmouth Medical Center

National Diabetes Fact Sheet, 2011

Clinical Policy Title: Applied behavior analysis

Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes

DIAGNOSIS OF DIABETES NOW WHAT?

Provider Bulletin December 2018 Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes

Clinical Policy Title: Statin use in adults and children

International Diabetes Center s Annual Symposium for Advanced Diabetes Educators: Discoveries in Diabetes: How They Will Change Your Practice

DIABETES MEASURES GROUP OVERVIEW

Professional CGM Reimbursement Guide

Clinical Policy Title: Discography

Can you see me now? Bringing DSME to rural S.C. via Telehealth. Mandy Floyd, RN Anita Longan, RDN, CDE, BC-ADM March 12, 2016

Clinical Policy Title: Pharmacogenomic tests for psychiatric medications

Effective Health Care Program

Clinical Policy: Gastric Electrical Stimulation Reference Number: CP.MP.40

About the Highmark Foundation

Diabetes Prevention in. Massachusetts: Prediabetes and the Diabetes Prevention Program. Diabetes Prevention and Control

Clinical Policy Title: Home phototherapy for hyperbilirubinemia

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

Diabetes Management, Equipment and Supplies

Comparative Effectiveness and Safety of Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus

National Diabetes Fact Sheet, 2007

Clinical Policy Title: Investigational (experimental) health services

Continuous Glucose Monitoring Devices Pharmacy Policy

Coverage Guidelines. Continuous Glucose Monitors (CGMs)

TUEC Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)

Clinical Policy Title: Ear tubes (tympanostomy)

Clinical Policy Title: Bone growth stimulators for non-healing fractures

National Diabetes Prevention Program Centers for Medicare & Medicaid Service Expansion. Tribal Leaders Diabetes Committee September 22, 2016

Diabetic Equipment and Supplies

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Corporate Medical Policy Investigational (Experimental) Services

Transcription:

Clinical Policy Title: Outpatient diabetes self-management training (DSMT) Clinical Policy Number: 06.02.02 Effective Date: July 1, 2013 Initial Review Date: April 23, 2013 Most Recent Review Date: March 15, 2017 Next Review Date: March 2018 Policy contains: Outpatient diabetes selfmanagement (DSMT). Certificate of Recognition. Diabetes mellitus. Related policies: CP# 08.02.07 CP# 06.02.03 CP# 06.02.01 Artificial pancreas device system Continuous interstitial glucose monitors (CGMS) Insulin infusion therapy (insulin pumps) ABOUT THIS POLICY: Keystone First has developed clinical policies to assist with making coverage determinations. Keystone First s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional societies, and peer-reviewed professional literature. These clinical policies along with other sources, such as plan benefits and state and federal laws and regulatory requirements, including any state- or plan-specific definition of medically necessary, and the specific facts of the particular situation are considered by Keystone First when making coverage determinations. In the event of conflict between this clinical policy and plan benefits and/or state or federal laws and/or regulatory requirements, the plan benefits and/or state and federal laws and/or regulatory requirements shall control. Keystone First s clinical policies are for informational purposes only and not intended as medical advice or to direct treatment. Physicians and other health care providers are solely responsible for the treatment decisions for their patients. Keystone First s clinical policies are reflective of evidence-based medicine at the time of review. As medical science evolves, Keystone First will update its clinical policies as necessary. Keystone First s clinical policies are not guarantees of payment. Coverage policy Keystone First considers the use of outpatient diabetes self-management and training (DSMT) to be clinically proven and, therefore, medically necessary when ordered by a qualified health care professional and when the following criteria are met: Patient eligibility criteria (must meet at least one of criterion A, B, C, or D) A. The individual is newly diagnosed with diabetes mellitus by means of one of the following: A fasting blood sugar greater than or equal to 126 mg/dl on two different occasions. A two-hour post-glucose challenge 200 mg/dl. A random glucose test > 200 mg/dl for an individual with symptoms of uncontrolled diabetes. An HbA1C level 6.5 percent. B. The individual diagnosed with diabetes exhibits poor glycemic control evidenced by a glycosylated 1

Patient eligibility criteria (must meet at least one of criterion A, B, C, or D) hemoglobin (HbA1C) 9.5 percent in the 90 days before attending the DSMT. C. The treating professional health care provider detects that the individual diagnosed with diabetes requires a change in the treatment regimen where re-education or refresher training is necessary (e.g., from no diabetes medication to any diabetes medication, or from oral diabetes medication to insulin). D. The treating professional health care provider detects that the individual with diagnosed diabetes is deemed to be at high risk based on either: Evidence of poor glycemic control, with documentation of acute episodes of severe hypoglycemia, or acute severe hyperglycemia within the past year that required third-party assistance for either emergency room visits or hospitalization. Documented complications including, but not limited to, one of the following: - An absence of feeling in the foot or other foot complications (e.g., foot ulcer, amputation). - Pre-proliferative or proliferative retinopathy, or prior laser treatment of the eye. - Renal complications related to diabetes (e.g., macroalbuminuria, elevated creatinine). and DSMT program criteria (criteria A, B, C, D, and E must be met) A. Assessment of the diabetic individual s specific education needs, including all of the following: Family involvement, social support, and community resources. Nutrition and meal planning, skin care, exercise, and physical activity needs. Use of medications, safety and effectiveness, and an insulin treatment plan developed specifically for the individual, where applicable. Prevention, detection, and treatment of acute and chronic complications. B. Identification of the individual s specific diabetes self-management goals. C. Behavioral intervention and education to help the individual achieve his or her identified diabetes selfmanagement goal, including: Instruction in blood glucose self-monitoring. Motivation for the individual to use the skills acquired with DSMT. D. Ongoing evaluation of the individual s actualization of his or her identified diabetic self-management goals. E. The DSMT includes a comprehensive plan of care that describes the content, number, frequency, and duration of the DSMT as applied to either of the following: Services furnished in a group setting of two to 20 individuals. The need for individual DSMT sessions is justified by one of the following: - Group sessions are unavailable within two months of the date the training is ordered. - The physician or professional health care provider orders additional insulin education. - The individual is unable to participate in a group setting due to, but not limited to, one of the following: Severe vision, hearing, or language limitations. Special conditions identified by the treating physician or professional health care provider. Limitations: 2

All other uses of DSMT are not medically necessary. An initial 10 hours of DSMT within a continuous 12-month period is medically necessary for a member diagnosed with diabetes. A maximum of two hours of DSMT each year is medically necessary for a member with diabetes, beginning with the calendar year in which the recipient received their initial training. The need for DSMT and program plan must be maintained and documented in the member s medical record. Included are statements regarding the number of hours, topics covered, and the member s need for individual or group training. DSMT is not medically necessary for a member who is a patient in a hospital, skilled nursing facility, hospice, or nursing home. DSMT in the home setting is an integral part of a home visit; as such it is not eligible for separate reimbursement. The health care provider maintains a certificate of recognition from the American Diabetes Association (ADA), American Association of Diabetes Educators (AADE), or other Centers for Medicare & Medicaid Services (CMS)-acknowledged certification entity that affirms recognized provider status for the diabetes educator and education program. Alternative covered services: Diabetes self-management education as part of an inpatient occurrence. Diabetes self-management education as an integral part of a home visit. Background Diabetes mellitus is a chronic endocrine disease that involves a detrimental change in the secretion of insulin from the pancreas marked by high levels of blood glucose resulting from defects in insulin production, insulin action, or both. Diabetes mellitus is classified as type 1 (destruction of insulin-producing pancreatic beta-cells) and type 2 (gradual loss of the ability to produce insulin). The risk of diagnosed diabetes is highest among those of Asian, Hispanic, and non-hispanic black descent (Centers for Disease Control and Prevention [CDC] 2014). Prediabetes is a condition in which the blood glucose levels are higher than normal, but are not yet high enough to be diagnosed as type 2 diabetes (T2DM). Interventions such as diet and exercise can correct prediabetes and prevent or delay T2DM. Diabetes and prediabetes may affect anyone at any time during his or her life span (CDC 2014). DSMT: Diabetes requires long-term medical management to limit the extent of complications associated with the disease. DSMT is an ongoing, collaborative process in which diabetes educators help diabetic individuals gain the knowledge, coping, problem-solving, decision making, and self-behavior skills needed to 3

successfully manage the disease and its associated comorbidities (Minet 2010). DSMT integrates functional, medical, cultural, psychosocial, and spiritual goals of care. The degree to which individuals are able to learn, process, and understand health information is a factor of their health literacy. Successful diabetes selfmanagement entails active participation in a large amount of tasks of varying complexity that integrate learned behaviors into the context of daily life (Wallace 2010). Searches Keystone First searched PubMed and the databases of: UK National Health Services Centre for Reviews and Dissemination. Agency for Healthcare Research and Quality s (AHRQ s) National Guideline Clearinghouse and other evidence-based practice centers. CMS. We conducted searches on January 18, 2017. Search terms were: "diabetes self-management," "diabetes mellitus/education" (MeSH), "diabetes mellitus/organization and administration" (MeSH), and "diabetes mellitus/prevention and control" (MeSH). We included: Systematic reviews, which pool results from multiple studies to achieve larger sample sizes and greater precision of effect estimation than in smaller primary studies. Systematic reviews use predetermined transparent methods to minimize bias, effectively treating the review as a scientific endeavor, and are thus rated highest in evidence-grading hierarchies. Guidelines based on systematic reviews. Economic analyses, such as cost-effectiveness, and benefit or utility studies (but not simple cost studies), reporting both costs and outcomes sometimes referred to as efficiency studies which also rank near the top of evidence hierarchies. Findings Evidence from systematic reviews shows that DSMT can significantly improve glycemic control, diabetes knowledge, self-management skills, and self-efficacy and empowerment (Steinsbekk 2012; Duke 2009; Couch 2008; Deakin 2005). DSMT and education are considered integral parts of diabetic care, and medical treatment without these components is considered inadequate (American Diabetes Association [ADA] 2014; Haas 2014). The ADA and the American Association of Diabetes Educators place the diabetic individual s condition, desires, abilities, and tolerances at the center of the decision-making process (Haas 2014). Typically, a certified diabetes educator performs a one-hour assessment to develop an appropriate education program tailored to the individual s specific needs. Group sessions are usually two hours in length, while individual diabetes education may use one hour sessions to address individual requirements. Evidence based standards guide instructions for nutrition (diet) and exercise, self-monitoring of blood 4

glucose, and the inclusion of an insulin treatment plan (for each individual who is insulin-dependent) or oral medication (for those on oral therapy). Presently, higher-intensity face-to-face interventions (group or one-to-one) set the current standard for DSMT. Computer-based, cellular phone, and web-based interventions are readily available tools that could improve health outcomes in diabetes care by facilitating intense patient self-management. For these interventions to improve outcomes, they must help patients improve their knowledge and understanding of diabetes and change their patterns of eating, physical activity, and adherence to treatment regimens. Their value has been demonstrated in other areas of chronic disease self-management. Policy updates: Two systematic reviews examined the role of information communication technology in facilitating diabetes self-management and improving patient outcomes (Pal, 2013; Hayes, 2014). The evidence from these systematic reviews is based on multiple randomized controlled trials (RCTs) of low to moderate quality with variable intervention protocols and reporting of study details that make the risk of bias difficult to determine in most cases. These systematic reviews found: Sufficient evidence to show that computer-based, cellular phone, and web-based interventions are safe interventions with minimal to no adverse effects reported. Insufficient evidence to support the routine use of computer-based, cellular phone, and webbased interventions in DSMT. There is low- to moderate-quality evidence of effectiveness showing that mobile phones and two-way communication with frequent feedback improve HbA1C and adherence to self-management regimens in adults in the short term, but evidence in children and adolescents is limited with inconsistent results. Insufficient evidence to support either the clinical relevance of these intermediate outcomes on health outcomes or the cost-effectiveness of these interventions compared to the current standards of care. A meta-analysis summarized the results of 62 studies, representing 67 RCTs, of the effect of consumer health information technologies on outcomes in DSMT (Or 2014). The use of these technologies was associated with significant reductions in HbA1C, blood pressure, total cholesterol, and triglycerides levels when compared with the usual care. However, only a small proportion of the trials reported positive effects on patient outcomes. The effectiveness of the technologies in improving patient outcomes still awaits confirmation in future studies. A comprehensive systematic review of 120 RCTs comprising more than 22,000 total participants and 118 unique interventions found robust data demonstrating that engagement in DSMT results in a statistically significant decrease in HbA1C levels (Chrval 2016). Combination DSMT resulted in the largest decreases in HbA1C (0.88) compared with only group, individual, and remote interventions. The magnitude of reductions in HbA1C in participants exposed to DSMT exceeded that of usual care by more than 0.5 percent for all modes of delivery other than primarily remote. However, only 12 studies offered remote interventions, and the results should be interpreted cautiously. More than 10 contact hours were 5

associated with a greater proportion of interventions with significant reduction in HbA1C (70.3 percent). In patients with persistently elevated glycemic values (HbA1C > 9), a greater proportion of studies reported statistically significant reduction in HbA1C (83.9 percent). The data suggest mode of delivery, hours of engagement, and baseline HbA1C can affect the likelihood of achieving statistically significant and clinically meaningful improvement in HbA1C. People with severe mental illness are at higher risk of developing T2DM. It is not clear if existing treatment guidelines for T2DM are generalizable to those with severe mental illness. One new Cochrane review found insufficient evidence from one low-quality RCT to determine if a tailored approach to diabetes education was more effective than usual diabetes care plus information in this population (McBain, 2016). These results do not change previous conclusions. Therefore no policy changes are warranted. Summary of clinical evidence: Citation Chrvala (2016) DSMT and support methods, providers, duration, and contact time on glycemic control in adults with T2DM McBain (2016) Cochrane review DSMT tailored for people with T2DM and severe mental illness Hayes (2014) Content, Methods, Recommendations Key points: Systematic review of 120 RCTs (11,854 participants in intervention group, 11,093 participants in control group) and 118 unique interventions. Overall quality: low with high risk of bias. Overall mean reduction in HbA1C was 0.74 and 0.17 for intervention and control groups, respectively; an average absolute reduction in HbA1C of 0.57. Combination DSMT resulted in the largest decreases in HbA1C (0.88) compared with group, individual, and remote interventions. Contact hours > 10 were associated with a greater proportion of interventions with significant reduction in HbA1C (70.3%). In patients with persistently elevated glycemic values (HbA1C > 9), a greater proportion of studies reported statistically significant reduction in HbA1C (83.9%). No differences in the mean change in HbA1C between single or team DSMT providers. DSME > 10 hours was associated with a slightly higher overall mean reduction in HbA1C. Key points: Systematic review of one RCT (three publications; 64 total participants with schizophrenia or schizoaffective disorder) comparing a 24-week Diabetes Awareness and Rehabilitation Training program to usual care plus information. Overall quality: unclear risk of bias. No significant improvement in total energy expenditure, HbA1C at six or 12 months of follow-up, or blood pressure. Anecdotal small improvements in body mass index, weight, diabetes knowledge, and self-efficacy immediately post-intervention, and knowledge also at six months. Key points: Information communication technology (ICT, cellular phones with short message service Systematic review of 18 RCTs (sample sizes: 30 to 463 patients). Overall quality: low to moderate. ICT improves HbA1C and adherence to self-management regimens in adults, but evidence in children and adolescents is limited with inconsistent results. ICT with two-way communication with frequent feedback is most effective. 6

Citation and web-based services) in DSMT Pal (2013) Content, Methods, Recommendations The use of ICT is safe with no reported side effects. Key points: Cochrane review Computer-based DSMT on health status and health-related quality of life (HRQOL) in adults with T2DM Systematic review of 16 RCTs (3,578 total patients). Overall quality: unclear risk of bias. No blinding, heterogeneous interventions, incomplete reporting of critical study design details. Age of participants was 46 67 years, mean time since diagnosis was six 13 years. The duration of the interventions one to 12 months. Three reported deaths. Computer-based DSMT has limited effectiveness: small benefits on glycemic control (pooled effect on HbA1C: -2.3 mmol/mol or -0.2% (95% confidence interval [CI] -0.4 to -0.1; P = 0.009; 2,637 participants; 11 trials). The effect size on HbA1C was larger in the mobile phone subgroup (mean difference in HbA1C -5.5 mmol/mol or -0.5% [95% CI -0.7 to -0.3]; P < 0.00001; 280 participants; three RCTs). Current interventions do not show adequate evidence for improving depression, HRQOL, weight, or other outcomes. No documented adverse effects. Two studies provided limited cost-effectiveness data one study found costs per patient of less than $140 (in 1997) and another showed no change in health behavior and resource utilization. References Professional society guidelines/other: Funnell MM, Brown TL, Childs BP, et al. National Standards for Diabetes Self-Management Education. Diabetes Care. 2011; 34(Suppl 1): S89 - S96. Haas L, Maryniuk M, Beck J, et al. National standards for diabetes self-management education and support. Diabetes Care. 2014; 37 Suppl 1: S144 - S153. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011; 17 Suppl 2: 1-53. Standards of Medical Care in Diabetes-2016: Summary of Revisions. Diabetes Care. 2016; 39 Suppl 1: S4-5. American Diabetes Association (ADA) website. http://care.diabetesjournals.org/content/39/supplement_1/s4.full. Accessed March 7, 2016. Peer-reviewed references: Couch R, Jetha M, Dryden DM, et al. Diabetes Education for Children With Type 1 Diabetes Mellitus and Their Families. Evidence Report/Technology Assessment No. 166. (Prepared by the University of Alberta/Capital Health Evidence-based Practice Center under Contract No. 290-02-0023.) AHRQ Publication 7

No. 08-E011. April 2008. Rockville, MD. AHRQ website. http://www.ahrq.gov/research/findings/evidencebased-reports/diabed-evidence-report.pdf. Accessed January 18, 2017. Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016; 99(6): 926 943. Deakin T, McShane CE, Cade JE, Williams RD. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005; (2): Cd003417. Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2009; (1): Cd005268. Hayes, Inc. Hayes Medical Directory Report. The Use of Information Communication Technology (ICT) to Improve Treatment Adherence in Patients with Diabetes. Lansdale, Pa. Hayes, Inc.; March 2014. Minet L, Moller S, Vach W, Wagner L, Henriksen JE. Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomized controlled trials. Patient Educ Couns 2010, 80: 29 41. National Diabetes Statistics Report, 2014. CDC website. http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html. Accessed January 18, 2017. National Diabetes Education Program. National Institute of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases website. http://ndep.nih.gov/. Accessed January 18, 2017. Pal K, Eastwood SV, Michie S, et al. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013; 3: Cd008776. Steinsbekk A, Rygg LO, Lisulo M, Rise MB, Fretheim A. Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with metaanalysis. BMC Health Serv Res. 2012; 12: 213. Wallace, A. Low Health Literacy: Overview, Assessment, and steps toward providing high-quality diabetes care. Diabetes Spectrum. 2010; 23(4): 220 227. CMS National Coverage Determinations (NCDs): NCD for Diabetes Outpatient Self-Management Training (40.1). CMS website. http://www.cms.gov/medicare-coverage-database/details/ncddetails.aspx?ncdid=251&bc=agaaqaaaaaaa&ncdver=1.accessed January 18, 2017. Transmittal 1255, Change 5433, May 25, 2007. CMS website. http://www.cms.gov/regulations-and- Guidance/Guidance/Transmittals/downloads/R1255CP.pdf. Accessed January 18, 2017. 8

CMS Coverage Issues Manual. Part 80: Patient education programs. 80-2: Outpatient diabetic education programs. September 2004. CMS website. http://www.cms.gov/regulations-and- Guidance/Guidance/Transmittals/downloads/R141CIM.pdf. Accessed January 18, 2017. Medicare Program; Expanded Coverage for Outpatient Diabetes Self-Management Training and Diabetes Outcome Measurements; Final Action. December 29, 2000. Federal Register website. https://www.federalregister.gov/articles/2000/12/29/00-32703/medicare-program-expanded-coveragefor-outpatient-diabetes-self-management-training-and-diabetes#h-12. Accessed January 18, 2017. Local Coverage Determinations (LCDs): No LCDs identified as of the writing of this policy. Commonly submitted codes Below are the most commonly submitted codes for the service(s)/item(s) subject to this policy. This is not an exhaustive list of codes. Providers are expected to consult the appropriate coding manuals and bill in accordance with those manuals. CPT Code Description Comment 97802 Medical nutrition therapy; initial assessment and intervention, individual, face-toface with the patient, each 15 minutes 97803 Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes 97804 Medical nutrition therapy, group (2 or more individual (s)), each 30 minutes. 98960 Education and training for patient self-management by a qualified, non-physician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; individual patient 98961 Education and training for patient self-management by a qualified, non-physician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 2-4 patients 98962 Education and training for patient self-management by a qualified, non-physician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 5-8 patients 99078 Physician or other qualified health care professional qualified by education, training, licensure/regulation (when applicable) educational services rendered to patients in a group setting (eg prenatal, obesity, or diabetic instructions) ICD-10 Code Description Comment E08.xx E09.xx E10.xx E11.xx E13.xx Diabetes mellitus due to underlying condition Drug or chemical induced diabetes mellitus Type 1 diabetes mellitus Type 2 diabetes mellitus Other specified diabetes mellitus 9

O24.xx Diabetes mellitus in pregnancy, childbirth, and the puerperium O99.81x Abnormal glucose complicating pregnancy, childbirth and the puerperium Z79.4 Long term (current) use of Insulin HCPCS Level II Code Description Comment G0108 Diabetes outpatient self-management training services (DSMT); individual session, face-to-face with the pt, each 30 minutes of training G0109 Diabetes outpatient self-management training services (DSMT), group session (2 or more), face-to-face with the pts, each 30 minutes of training per 30 minutes S9140 Diabetic management program, follow-up visit to non-md provider Not covered by S9141 Diabetic management program, follow-up visit to MD provider Not covered by S9455 Diabetic management program, group session Not covered by S9460 Diabetic management program, nurse visit Not covered by S9465 Diabetic management program, dietitian visit Not covered by 10